DE CARLO, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 3.740
AS - Asia 2.866
EU - Europa 1.214
SA - Sud America 475
AF - Africa 113
OC - Oceania 1
Totale 8.409
Nazione #
US - Stati Uniti d'America 3.642
SG - Singapore 992
CN - Cina 711
HK - Hong Kong 522
BR - Brasile 389
IT - Italia 360
VN - Vietnam 311
DE - Germania 184
SE - Svezia 172
GB - Regno Unito 97
FI - Finlandia 85
FR - Francia 62
BG - Bulgaria 57
RU - Federazione Russa 55
IN - India 53
JP - Giappone 53
CA - Canada 40
KR - Corea 36
TR - Turchia 32
MX - Messico 29
BD - Bangladesh 28
CI - Costa d'Avorio 28
AR - Argentina 26
IQ - Iraq 25
ZA - Sudafrica 25
AT - Austria 22
NL - Olanda 21
PK - Pakistan 21
UA - Ucraina 20
CO - Colombia 18
EC - Ecuador 15
EG - Egitto 14
PL - Polonia 14
ES - Italia 13
MA - Marocco 13
KE - Kenya 12
ID - Indonesia 11
CH - Svizzera 10
SA - Arabia Saudita 10
UZ - Uzbekistan 10
VE - Venezuela 9
SN - Senegal 8
BE - Belgio 7
JM - Giamaica 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
BO - Bolivia 5
CZ - Repubblica Ceca 5
HN - Honduras 5
AL - Albania 4
CL - Cile 4
IE - Irlanda 4
KG - Kirghizistan 4
LT - Lituania 4
MY - Malesia 4
NP - Nepal 4
PH - Filippine 4
PY - Paraguay 4
TT - Trinidad e Tobago 4
CG - Congo 3
CR - Costa Rica 3
JO - Giordania 3
KZ - Kazakistan 3
LB - Libano 3
MD - Moldavia 3
OM - Oman 3
PA - Panama 3
PT - Portogallo 3
UY - Uruguay 3
BB - Barbados 2
BH - Bahrain 2
DZ - Algeria 2
GT - Guatemala 2
IL - Israele 2
MK - Macedonia 2
NG - Nigeria 2
PE - Perù 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BY - Bielorussia 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
KW - Kuwait 1
KY - Cayman, isole 1
LK - Sri Lanka 1
MN - Mongolia 1
NO - Norvegia 1
PR - Porto Rico 1
Totale 8.404
Città #
Singapore 581
Hong Kong 515
Santa Clara 473
Dallas 389
San Jose 381
Ashburn 368
Shanghai 260
Boardman 153
Woodbridge 141
Fairfield 133
Ho Chi Minh City 100
Chandler 96
Los Angeles 94
Munich 89
Beijing 87
Milan 84
Houston 80
Hanoi 74
New York 72
Seattle 69
Ann Arbor 66
Wilmington 59
Sofia 57
Hefei 55
Cambridge 47
Tokyo 46
Helsinki 45
London 44
Frankfurt am Main 41
Council Bluffs 35
Seoul 35
São Paulo 35
Princeton 30
Abidjan 28
Buffalo 28
Lauterbourg 28
Lawrence 27
Redondo Beach 27
Chicago 23
Turku 23
Florence 22
Medford 22
Hyderabad 20
Ottawa 20
Nuremberg 18
Rome 18
Ogden 17
Jacksonville 16
Atlanta 15
Columbus 15
Rio de Janeiro 15
San Diego 15
Brooklyn 12
Istanbul 12
Phoenix 12
Nairobi 11
North Bergen 11
Orem 11
Pisa 11
Salt Lake City 11
Des Moines 10
Easley 10
Fuzhou 10
Haiphong 10
Nanjing 10
Vienna 10
Baltimore 9
Denver 9
Düsseldorf 9
Hải Dương 9
Mexico City 9
Tashkent 9
Baghdad 8
Da Nang 8
Dakar 8
Miami 8
Warsaw 8
Belo Horizonte 7
Brussels 7
Cascina 7
Chennai 7
Dong Ket 7
Genoa 7
Guangzhou 7
Izmir 7
Lancaster 7
Naples 7
San Francisco 7
Bari 6
Bern 6
Brasília 6
Bremen 6
Brusaporto 6
Cairo 6
Campinas 6
Casablanca 6
Dearborn 6
Falls Church 6
Gallarate 6
Lappeenranta 6
Totale 5.625
Nome #
Effects of levosimendan in patients with severe functional mitral regurgitation undergoing MitraClip implantation 187
Transcathether aortic valve implantation with the new repositionable self-expandable Evolut R versus CoreValve system: A case-matched comparison 186
Interactions Between Reciprocal ST-Segment Downsloping During ST-Elevated Myocardial Infarction and Global Cardiac Perfusion and Functional Abnormalities 180
Prognostic Significance of Change in the Left Ventricular Ejection Fraction After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis and Left Ventricular Dysfunction 177
Left ventricular stiffness predicts outcome in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation 176
Multislice computed tomography SYNTAX score for coronary artery disease evaluation prior to transcatheter aortic valve implantation 171
One-year clinical results of the Italian diffuse/multivessel disease ABSORB prospective registry (IT-DISAPPEARS) 153
Non-continuous mobile electrocardiogram monitoring for post-transcatheter aortic valve replacement delayed conduction disorders put to the test 151
Impact of abciximab on distal embolization induced by primary angioplasty 147
Prognostic Role of Sonographic Decongestion in Patients with Acute Heart Failure with Reduced and Preserved Ejection Fraction: A Multicentre Study 145
Heterotopic Transcatheter Tricuspid Valve Replacement in Severe Tricuspid Regurgitation and Refractory Right Heart Failure 144
Evolving paradigms in transcatheter aortic valve replacement: results from a high-volume, single center experience 142
Distal embolization during primary angioplasty: histopathologic features and predictability 139
Avoiding cerebrovascular events after TAVI: Need for an integrated approach 139
Evolution, Predictors, and Neurocognitive Effects of Silent Cerebral Embolism During Transcatheter Aortic Valve Replacement 139
Anaesthetic management of transcatheter aortic valve implantation: Results from the Italian CoreValve registry 135
A case report of multisite arterial thrombosis in a patient with coronavirus disease 2019 (COVID-19) 133
Histopathology, and Impact of Abciximab Pre-Treatment 126
Combining cardiopulmonary exercise testing with echocardiography: a multiparametric approach to the cardiovascular and cardiopulmonary systems 122
Endothelial function in cardiovascular medicine: a consensus paper of the European Society of Cardiology Working Groups on Atherosclerosis and Vascular Biology, Aorta and Peripheral Vascular Diseases, Coronary Pathophysiology and Microcirculation, and Thrombosis 122
Anticoagulation in venous thromboembolism in Behçet’s syndrome: friend or foe? 119
Impact of Pulmonary Hypertension on Outcomes After Transcatheter Tricuspid Valve Edge-to-Edge Repair 118
Transthoracic and transoesophageal echocardiography for tricuspid transcatheter edge-to-edge repair: a step-by-step protocol 116
ImpaCt of an optimal Implantation strategy on Absorb long-term Outcomes: the CIAO Registry 114
Coronary Protection to Prevent Coronary Obstruction During TAVR: A Multicenter International Registry 113
Atrial Secondary Tricuspid Regurgitation: Insights Into the EuroTR Registry 112
Bio-Humoral and Non-Invasive Haemodynamic Correlates of Renal Venous Flow Patterns across the Heart Failure Spectrum 109
Evolution, Predictors, and Neurocognitive Effects of Silent Cerebral Embolism During Transcatheter Aortic Valve Replacement 108
Antithrombotic therapy for peripheral revascularisation 108
Transcatheter aortic valve replacement with or without anesthesiologist: results from a high-volume single center 107
mPAP/CO Slope and Oxygen Uptake Add Prognostic Value in Aortic Stenosis 107
Mechanical prevention of distal embolization during primary angioplasty - Safety, feasibility, and impact on myocardial reperfusion 106
Antiplatelet therapy in patients with acute coronary syndromes and thrombocytopaenia: awaiting for evidence 105
Haemodynamic and metabolic phenotyping of patients with aortic stenosis and preserved ejection fraction: a specific phenotype of heart failure with preserved ejection fraction? 102
Distal embolization during angioplasty for acute myocardial infarction: is pharmacological protection enough? 101
Vascular Access in Patients With Peripheral Arterial Disease Undergoing TAVR: The Hostile Registry 98
Tricuspid Transcatheter Orthotopic and Heterotopic Replacement Screening F.A.I.L.: First Attempt In Learning! 93
High-intensity transcranial Doppler signals in patients wearing heart valve prostheses: a prospective study. 90
Antithrombotic therapy following revascularization for chronic limb-threatening ischaemia: a European survey from the ESC Working Group on Aorta and Peripheral Vascular Diseases 89
Prospective evaluation of frequency and nature of transcranial high-intensity Doppler signals in prosthetic valve recipients 89
Transcatheter aortic valve replacement with the self-expanding ACURATE Neo2 in patients with horizontal aorta: Insights from the ITAL-neo registry 88
Guideline-Directed Medical Therapy and Survival After TEER for Secondary Mitral Regurgitation With Right Ventricular Impairment 87
Transcatheter Aortic Valve Replacement With Self-Expanding ACURATE neo2: Postprocedural Hemodynamic and Short-Term Clinical Outcomes 86
Outcomes of Patients With Very Severe Aortic Stenosis Treated With Transcatheter Aortic Valve Implantation 86
Illusory Coronary Obstruction After BASILICA: In IVUS We Trust! 82
To Revascularize or Not to Revascularize TAVR Candidates?: That Is the (Lingering) Question 82
Elderly patients with non-ST-elevation acute coronary syndromes: A call for action 72
Impact of balloon post-dilation on valve durability and long-term clinical outcomes after self-expanding transcatheter aortic valve implantation 70
Effects of levosimendan therapy in patients with severe functional mitral regurgitation and chronic heart failure undergoing mitraclip implantation: a single-centre experience 68
Performance of 21-mm size perimount aortic bioprosthesis in the elderly 67
[Myocardial revascularization in patients with ischemic cardiomyopathy and left ventricular dysfunction] 66
Istantaneus wave-free ratio (IFR) versus non-invasive stress imaging to detect myocardial ischaemia 66
Cardiopulmonary exercise testing in patients with 21mm St. Jude Medical aortic prosthesis 64
Chimney technique and bioprosthetic valve fracture during valve-in-valve transcatheter aortic valve implantation: case report 62
Malnutrition and outcomes in patients with tricuspid regurgitation undergoing transcatheter tricuspid valve repair 61
P-wave signal-averaged electrocardiogram predicts atrial fibrillation after coronary artery bypass grafting 60
Management of patients with poly-vascular disease: Priorities for revascularization procedures 59
Editor's Choice – European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease 59
How transcatheter aortic valve implantation can revive balloon aortic valvuloplasty 59
Ostial and midshaft lesions vs. bifurcation lesions in 1111 patients with unprotected left main coronary artery stenosis treated with drug-eluting stents: Results of the survey from the Italian Society of Invasive Cardiology 57
Aortobronchial fistula after coarctation repair - Reply 57
Hemodynamic assessment of the Medtronic Mosaic® bioprosthesis in the aortic position 56
Symptomatic improvement after transmyocardial laser revascularization: How long does it last? 56
Antithrombotic treatment following revascularization for chronic limb-threatening ischaemia: a scientific statement of the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases and the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy 55
Transaxillary versus transaortic approach for transcatheter aortic valve implantation with CoreValve Revalving System: Insights from multicenter experience 55
Ascending aorta dissection after aortic valve replacement 54
[Myocardial revascularization with arterial conduits: comparison of bilateral internal mammary artery and single internal mammary artery] 53
[Transmyocardial revascularization with a holmium laser: preliminary results] 53
Mitral valve annuloplasty for degenerative disease: Assessment of four different techniques 52
Acute-phase reactants in acute myocardial infarction: Impact on 5-year prognosis 52
Are coronary angioplasty results equal in men and women? 49
The sorin bicarbon bileaflet prosthesis: a three-institutional 7-year follow-up 48
Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: The GEPRESS study 47
Atherosclerotic Renovascular Disease: A KDIGO (Kidney Disease: Improving Global Outcomes) Controversies Conference 46
Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference 44
Transcatheter mitral valve repair and replacement. A critical review of current real-world practice 41
Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: A consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy 40
Hemodynamic and Metabolic-Inflammatory Phenotyping Across the Cardiac Index Spectrum in Moderate and Severe Tricuspid Regurgitation: Prognostic Implications 40
International public awareness of peripheral artery disease 39
Follow-up of patients after revascularisation for peripheral arterial diseases: a consensus document from the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases and the European Society for Vascular Surgery 37
Editor's Choice – 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS) 35
The role of ventricular–arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association 35
The year in cardiology 2016: Peripheral circulation 32
The 2021 ESC guidelines on cardiovascular prevention: Whether the ends justify the means 31
Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: Systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases 30
Impact of Acute Coronary Syndromes on Two-Year Clinical Outcomes in Patients With Unprotected Left Main Coronary Artery Stenosis Treated With Drug-Eluting Stents 29
Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial 29
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases 29
Efficacy and safety of antiplatelet therapies in symptomatic peripheral artery disease: A systematic review and network meta-analysis 29
The year in cardiology: aorta and peripheral circulation 28
The wrecking ball effect of a right atrial myxoma 27
Effects of statin therapy on platelet reactivity after percutaneous coronary revascularization in patients with acute coronary syndrome 26
Combined retrograde-antegrade external iliac artery occlusion recanalization through collaterals: Description of a new technique 26
Follow-up of Patients After Revascularisation for Peripheral Arterial Diseases: A Consensus Document From the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases and the European Society of Vascular Surgery 26
Impact of Bifurcation Technique on 2-Year Clinical Outcomes in 773 Patients With Distal Unprotected Left Main Coronary Artery Stenosis Treated With Drug-Eluting Stents 25
Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention 25
The sorin bicarbon bileaflet prosthesis: a three-institutional 7-year follow-up 24
Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: Insights from a multicenter registry of 975 patients 24
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS) 24
Rheolytic thrombectomy: Any role left? 23
Totale 8.050
Categoria #
all - tutte 25.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.856


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202127 0 0 0 0 0 0 0 0 0 0 0 27
2021/2022299 6 7 0 12 51 41 55 9 16 4 28 70
2022/2023434 57 73 29 17 39 52 11 25 91 4 29 7
2023/2024509 27 30 31 20 63 153 19 5 7 15 48 91
2024/20252.904 16 141 113 115 278 430 174 114 257 304 332 630
2025/20263.634 252 496 401 278 370 242 519 169 272 336 155 144
Totale 8.616